Results from the phase 3 ENDURE trial (NCT03117816), newly published in Leukemia, demonstrate that ropeginterferon alfa-2b ...
All three of the patients with diffuse large B-cell lymphoma responded to the alpha-interferon and rituximab, and were continued on alpha-interferon. One patient had a partial response that has lasted ...
Please provide your email address to receive an email when new articles are posted on . The addition of interferon alfa to temozolomide significantly extended survival among patients with newly ...
According to an old medical maxim repeated in the New England Journal of Medicine last week, symptoms of the common cold, “if treated vigorously, will go away within seven days, whereas if left alone ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Intron A is an injectible recombinant ...
BETHESDA, Md.--(BUSINESS WIRE)-- The International Society for Interferon and Cytokine Research (ISICR) announced today that Eleanor Fish, Ph.D., and Sergei Kotenko, Ph.D., will share the 2010 Seymour ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Intron A is an injectible recombinant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback